Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KBP-042 in Type 2 Diabetes
NCT03230786Phase 2Completed
- Sponsor
- KeyBioscience AG
- Start
- Aug 2017
- Primary completion
- Jul 2018
- Modality
- Peptides, Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of KBP-042 in type 2 diabetes mellitus (T2DM), sponsored by KeyBioscience AG. Started Aug 2017; status: completed.
02
Drugs
KBP-042
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03230786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03230786.